Characteristics | NGR (Group I) (n = 1170) | IGR (Group II) (n = 389) | DM (Group III) (n = 343) | P-value | |||
---|---|---|---|---|---|---|---|
All | I vs. II | II vs. III | I vs. III | ||||
Age (years) | 57.1 ± 8.7 | 57.5 ± 9.1 | 58.1 ± 8.6 | 0.19 | 1.000 | 1.000 | 0.216 |
BMI (Kg · m-2) | 23.3 ± 3.6 | 24.6 ± 3.5 | 25.2 ± 4.0 | <0.01 | <0.001 | 0.120 | <0.001 |
WC (cm) | 81.1 ± 9.4 | 84.8 ± 9.2 | 86.8 ± 9.1 | <0.01 | <0.001 | 0.011 | <0.001 |
SBP (mmHg) | 124 ± 16 | 129 ± 18 | 132 ± 17 | <0.01 | <0.001 | 0.017 | <0.001 |
DBP (mmHg) | 79 ± 10 | 81 ± 10 | 83 ± 9 | <0.01 | 0.028 | 0.015 | <0.001 |
TC (mmol/L) | 5.17 ± 0.95 | 5.32 ± 0.97 | 5.39 ± 1.00 | <0.01 | 0.028 | 0.956 | 0.001 |
TG (mmol · L-1) | 1.45 ± 1.02 | 1.79 ± 1.17 | 2.15 ± 2.04 | <0.01 | <0.001 | <0.001 | <0.001 |
HDL-C (mmol · L-1) | 1.44 ± 0.34 | 1.34 ± 0.31 | 1.27 ± 0.29 | <0.01 | <0.001 | 0.011 | <0.001 |
SCr (umol · L-1) | 66.0 ± 12.7 | 65.5 ± 13.8 | 64.0 ± 14.8 | 0.04 | 1.000 | 0.371 | 0.041 |
eGFR (ml · min-1 · 1.73 m-2) | 99.4 ± 16.9 | 100.9 ± 18.6 | 105.6 ± 22.4 | <0.01 | 0.515 | 0.002 | <0.001 |
FPG (mmol · L-1) | 5.22 ± 0.45 | 5.85 ± 0.61 | 8.30 ± 2.62 | <0.01 | <0.001 | <0.001 | <0.001 |
2hPG (mmol · L-1) | 5.77 ± 1.11 | 8.15 ± 1.50 | 14.63 ± 5.03 | <0.01 | <0.001 | <0.001 | <0.001 |
HbA1c (%) | 5.5 ± 0.4 | 5.7 ± 0.5 | 7.2 ± 1.6 | <0.01 | <0.001 | <0.001 | <0.001 |
Hypertension (%) | 462 (39.5) | 212 (54.5) | 231 (65.3) | <0.01 | <0.001 | 0.003 | <0.001 |
Dyslipidemia (%) | 305 (26.1) | 160 (41.1) | 173 (48.9) | <0.01 | <0.001 | 0.033 | <0.001 |
CVD (%) | 66 (5.6) | 34 (8.7) | 37 (10.5) | <0.01 | 0.031 | 0.350 | 0.001 |
PAD (%) | 38 (3.3) | 19 (4.9) | 15 (4.2) | 0.23 | 0.323 | 0.334 | 0.150 |